ICON plc’s ICLR focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added positive. The stock carries a Zacks Rank #2 ...
The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback